Stockreport

Atea Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF trials (C-BEYOND — enrollment complete, mid-2026 readout; C-FORWARD — enrollment through mid-2026, year-end readout) testing bemnifosbuvir/ruzasvir versus sofosbuvir/vel [Read more]